Keryx Seeks To Scrap Shareholder Stock-Drop Suit
By Darcy Reddan ( October 3, 2017, 6:48 PM EDT) -- Keryx Biopharmaceuticals Inc. argued Monday that it shouldn't have to face a shareholder class action over alleged problems with a drug supply chain that resulted in a decline in stock value, claiming in a Massachusetts federal court filing that the shareholders failed to recognize the need for a different contractor for each production phase. ...
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.